American Shared Hospital Servic
2.2100-0.02 (-0.9%)
Oct 29, 4:00:00 PM EDT · NYSE American · AMS · USD
Key Stats
Market Cap
14.39MP/E (TTM)
-Basic EPS (TTM)
-0.38Dividend Yield
0%Recent Filings
8-K
Q2 revenue edges up 0.2%
American Shared Hospital Services reported Q2 2025 revenue of $7.1 million, up 0.2% year-over-year but down from last year's bargain purchase gain that boosted profits. Direct patient services surged 11% to $3.5 million, fueled by Rhode Island centers and Puebla, Mexico launch, while leasing dipped 8% due to expired Gamma Knife contracts and cyclical proton therapy dips. Expansion shines. Net loss hit $0.3 million, yet Adjusted EBITDA held at $1.7 million amid rising volumes.
10-Q
Q2 FY2025 results
American Shared Hospital Services posted Q2 revenue of $7.1M, up slightly y/y but flat q/q amid leasing declines offset by direct patient services growth from the Rhode Island centers acquired in May 2024 for $2.85M cash, recognizing a bargain purchase gain last year. Gross margin shrank to 23.1% from 35.0% y/y, pressured by higher operating costs in the new facilities, while operating loss widened to $0.5M from near breakeven; net loss hit $0.3M or $0.04 per diluted share on 6.6M shares, versus $3.6M profit last year driven by the acquisition gain. YTD revenue climbed 7.5% to $13.2M, but net loss deepened to $0.9M or $0.14 per share from $3.7M profit, with EPS aligning to weighted shares and no anti-dilution. Cash held steady at $11.1M with $2.1M operating cash flow, supporting $19.1M debt at SOFR+3% (7.49%); free cash flow not disclosed in the 10-Q. Procedure volumes dipped across Gamma Knife and PBRT segments due to contract expirations and cycles. Debt covenants slipped temporarily at quarter-end but recovered by July. Competition from alternative therapies remains a key risk.
8-K
Shareholders approve board, pay
American Shared Hospital Services held its annual shareholder meeting on June 26, 2025, with 83.46% quorum. Shareholders elected Daniel G. Kelly, Jr., Kathleen Miles, Raymond C. Stachowiak, and Vicki L. Wilson to the board. They approved executive compensation, annual advisory votes on pay, and ratified Baker Tilly US, LLP as auditors. Strong support signals board stability.
8-K
Auditor change via merger
American Shared Hospital Services' auditor Moss Adams resigned on June 3, 2025, following its merger with Baker Tilly US, LLP, which the Audit Committee promptly approved as the new independent firm. Prior audits for 2023 and 2024 carried clean opinions, with no disagreements but an unremediated material weakness in internal controls due to insufficient personnel. The switch ensures seamless continuity. Moss Adams concurs with these disclosures.
10-Q
Q1 FY2025 results
American Shared Hospital Services posted Q1 FY2025 revenue of $6.1M, up 17% y/y from $5.2M, driven by direct patient services surging to $3.1M from $1.0M thanks to Rhode Island centers acquired in May 2024 for $2.9M cash (60% interest, recognizing $4.7M facilities and $2.4M medical equipment over 15 and 4 years) and Puebla's July 2024 launch, while leasing dipped to $3.0M from $4.3M on expired Gamma Knife contracts and softer PBRT volumes. Gross margin shrank to 15.4% from 41.1% as operating costs climbed 68% y/y to $5.2M, mainly from new sites, yielding an operating loss of $1.3M versus $0.1M last year; net loss hit $0.6M or $0.10 per diluted share on 6.6M shares, differing from operating by interest expense of $0.4M. Cash rose to $11.2M with $2.5M operating inflow, but free cash flow stood at -$1.5M (derived) after $4.0M capex; total debt was $19.9M at SOFR+3% with $5M revolver availability and covenant compliance. Volumes fell, though. New ventures demand capital.
ACHC
Acadia Healthcare Company, Inc.
23.01-0.16
AIRS
AirSculpt Technologies, Inc.
10.90-0.67
AMN
AMN Healthcare Services Inc
20.63-0.10
AONC
American Oncology Network, Inc.
9.00-0.15
ARAY
Accuray Incorporated
1.44-0.04
ARDT
Ardent Health, Inc.
15.01-0.08
CCM
Concord Medical Services Holdin
5.30+0.06
CYH
Community Health Systems, Inc.
4.21+0.09
NUTX
Nutex Health Inc.
127.83-0.85
SRXH
SRX Health Solutions, Inc.
0.34-0.03